ESSA Pharma Inc.: cashflow_investing
| Value | {"amount": -11000040, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2021-10-01 – 2021-12-31 |
| Status | current |
| Entity | ESSA Pharma Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:47:45.295254+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/6e422fcd-c699-40ba-8249-0856ca7fe815
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-22-000740 · Open the official SEC filing →Retrieved: 2026-08-19T16:47:45.295254+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001633932/cashflow-investing/2021-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/6e422fcd-c699-40ba-8249-0856ca7fe815
History
- no predecessors — first report